Back to search

Article

Molecular and structural characterization of lenalidomide-mediated sequestration of eIF3i

2022-08-04

Abstract excerpt

<h4>ABSTRACT</h4> Lenalidomide is a ligand of the E3 ligase substrate adaptor cereblon (CRBN) that achieves its clinical effects in part by promotion of substrate recruitment and degradation. In contrast to prior substrates, eIF3i is recruited but not degraded upon complex formation with lenalidomide and CRBN, although the structural details and mechanistic outcomes of this interaction are unresolved. Here, we ch...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b05ac4ac-2208-5948-9509-b67b5f09081e
DOI
10.1101/2022.08.03.502648
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular and structural characterization of lenalidomide-mediated sequestration of eIF3iDOI 10.1101/2022.08.03.502648
Select a neighboring publication to make it the new centre.